Management of HER2 Low and HER2 Ultra Low - Greg Vidal, MD, PhD
In this session, Dr Gregory Vidal considers issues in management of HER2-Low and HER2-Ultra-Low breast cancers.
▶︎
Management of HER2+ Breast Cancer - Amina Chaudhry, MD
▶︎
NSCLC: Essential NGS Testing, Biomarkers, and Targeted Therapies - Shayma Kazmi, MD, RPh
▶︎
Where is AI Going in Oncology - Ravi Parikh, MD, MPP, FACP
▶︎
Phase 2 Study of Multi-Cancer Detection from Breath Samples
▶︎
Updates in Prostate Cancer - Daniel Vaena, MD
▶︎
Updates in Non Prostate Urogenital Cancers - Sandy Srinivas, MD
▶︎
Improving Transdermal Fentanyl Prescribing
▶︎
How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎
Expanding the Horizon in Metastatic Breast Cancer - Reshma Mahtani , DO
▶︎
Indistinguishable from Magic: When Fantasy and Science Fiction Meet the Science of Medicine
▶︎
Genitourinary Cancer Panel Discussion - Brad Somer, MD (Moderator)
▶︎
Updates in Gastrointestinal Cancers - Deepak Bhamidpati, MD
▶︎
Overcoming Challenges to Treatment Adherence
▶︎
Threats and Opportunities of IRA and MFN in Oncology - Barbara McAneny, MD, FASCO, MACP.
▶︎
Examining AI Use Cases at Sylvester Comprehensive Cancer Center
▶︎
I Was An MIT Educated Neurosurgeon Now I'm Unemployed And Alone In The Mountains How Did I Get Here?
▶︎
Transitioning to Outpatient Bite Therapy - Jason Chandler MD
▶︎
High CAC Score: What It Means and Exactly What to Do Next
▶︎
Nutrition in Cancer Care – David James, ND
▶︎